BLT benitec biopharma limited

Hoyland - yes I think so unless they've split sometime quite...

  1. 2,327 Posts.
    lightbulb Created with Sketch. 12
    Hoyland - yes I think so unless they've split sometime quite recent. There's other info online on the J&J / Calimmune link (not much - Calimmune very low profile) but here's Geoff Symond's bio below for upcoming World Gene Therapy Congress (London May 2012):


    "Geoff Symonds is Chief Scientific Officer of Calimmune, a biotech start-up company with laboratories both in Australia and the USA, and a Conjoint Professor in the Faculty of Medicine at the University of New South Wales in Sydney, Australia. He has been involved in research aimed at understanding normal and abnormal hematopoiesis for three decades, including 18 years overseeing the research and development of cell-delivered HIV gene therapy at Johnson and Johnson Research that progressed to a Phase II study. As Chief Scientific Officer of Calimmune, he has, in a short span of time, guided their present lead construct through pre-clinical studies, including pilot vector manufacture and a GLP Pharm/Tox humanized mouse study for a planned IND submission in 2012. He has approximately 100 publications, several patents and a long-standing interest in the use of retroviral vectors for gene therapy."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.